Myriad Genetics (MYGN) News Today $4.33 +0.18 (+4.34%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$4.45 +0.12 (+2.77%) As of 07:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MYGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Myriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025May 27 at 9:28 PM | insidermonkey.comMyriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025May 27 at 9:15 PM | msn.comMyriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual MeetingMay 27 at 4:05 PM | globenewswire.comSpotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1May 27 at 6:53 AM | finance.yahoo.comMyriad Genetics, Inc. (NASDAQ:MYGN) Receives $15.79 Consensus Price Target from AnalystsMay 24, 2025 | americanbankingnews.comScotiabank Downgrades Myriad Genetics (NASDAQ:MYGN) to Sector PerformScotiabank downgraded shares of Myriad Genetics from a "sector outperform" rating to a "sector perform" rating and set a $6.00 target price on the stock. in a research report on Wednesday.May 23, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Cut to "Sector Perform" at ScotiabankMay 23, 2025 | americanbankingnews.comMyriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Recommendation of "Hold" from BrokeragesMyriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has received a consensus rating of "Hold" from the seventeen ratings firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have aMay 23, 2025 | marketbeat.comScotiabank cuts Myriad Genetics stock rating, slashes price targetMay 22, 2025 | uk.investing.comPoint72 Asset Management L.P. Sells 715,107 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Point72 Asset Management L.P. lowered its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 67.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 348,604 shares of the company's stock after sellingMay 22, 2025 | marketbeat.comScotiabank Downgrades Myriad Genetics (MYGN)May 21, 2025 | msn.comMYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer RampMay 19, 2025 | finance.yahoo.comBank of America Corp DE Sells 495,911 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Bank of America Corp DE lowered its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,402,708 shares of the company's stock after selling 495,91May 19, 2025 | marketbeat.comNorthern Trust Corp Buys 64,923 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Northern Trust Corp increased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,032,132 shares of the company's stock after purchasing an additional 64,923 shares during the pMay 18, 2025 | marketbeat.com83,382 Shares in Myriad Genetics, Inc. (NASDAQ:MYGN) Acquired by Balyasny Asset Management L.P.Balyasny Asset Management L.P. acquired a new position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 83,382 shares of the company's stock, valued at approximately $1,May 16, 2025 | marketbeat.comUpdated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences | MYGN ...May 14, 2025 | gurufocus.comUpdated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare ConferencesMay 14, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Purchases 668,429 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)D. E. Shaw & Co. Inc. lifted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 58.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,819,814 shares of the company's stock after aMay 14, 2025 | marketbeat.com3 of Wall Street’s Favorite Stocks in Dangerous TerritoryMay 13, 2025 | finance.yahoo.comWolfe Research Downgrades Myriad Genetics (NASDAQ:MYGN) to Peer PerformWolfe Research cut Myriad Genetics from an "outperform" rating to a "peer perform" rating in a research note on Thursday.May 10, 2025 | marketbeat.comMyriad Genetics, Inc. (MYGN): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside PotentialMay 9, 2025 | msn.comMyriad Genetics (NASDAQ:MYGN) Downgraded to Equal Weight Rating by Wells Fargo & CompanyWells Fargo & Company cut Myriad Genetics from an "overweight" rating to an "equal weight" rating and set a $6.00 price objective for the company. in a research report on Wednesday.May 9, 2025 | marketbeat.comSecurities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmMay 8, 2025 | businesswire.comMyriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 8, 2025 | businesswire.comMyriad Genetics, Inc. (NASDAQ:MYGN) Just Reported Earnings, And Analysts Cut Their Target PriceMay 8, 2025 | finance.yahoo.comMyriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call TranscriptMay 8, 2025 | msn.com4MYGN : What Analysts Are Saying About Myriad Genetics StockMay 8, 2025 | benzinga.comMyriad Genetics, Inc. (NASDAQ:MYGN) Stock Position Reduced by Dimensional Fund Advisors LPDimensional Fund Advisors LP trimmed its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 6.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,272,355 shares of the company's stock after selling 151,122 shaMay 8, 2025 | marketbeat.comFirst Trust Advisors LP Sells 46,831 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)First Trust Advisors LP trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,545 shares of the company's stock after selling 4May 8, 2025 | marketbeat.comSecurities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 7, 2025 | businesswire.comMyriad Genetics Faces Challenges Amid Prenatal Testing GrowthMay 7, 2025 | tipranks.comWhy Myriad Genetics (MYGN) Stock Is Down TodayMay 7, 2025 | msn.comWhy Myriad Genetics (MYGN) Stock Is Down TodayMay 7, 2025 | msn.comMyriad Genetics Inc (MYGN) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...May 7, 2025 | gurufocus.comMyriad Genetics, Inc. (MYGN) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comMyriad Genetics, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 7, 2025 | seekingalpha.comMyriad Genetics Faces Revenue Declines and Strategic Challenges: Hold Rating MaintainedMay 6, 2025 | tipranks.comMyriad Genetics (NASDAQ:MYGN) Misses Q1 Sales Targets, Stock Drops 14.5%May 6, 2025 | msn.comMyriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial GuidanceMay 6, 2025 | gurufocus.comMyriad Genetics (MYGN) Lowers 2025 Guidance Following Revenue Miss | MYGN Stock NewsMay 6, 2025 | gurufocus.comMyriad Genetics Inc Reports Q1 2025 Earnings: EPS of $(0. ...May 6, 2025 | gurufocus.comMyriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial GuidanceMay 6, 2025 | globenewswire.comMyriad Genetics's Earnings: A PreviewMay 5, 2025 | benzinga.comWhat To Expect From Myriad Genetics’s (MYGN) Q1 EarningsMay 5, 2025 | msn.comMyriad Genetics: Significantly Undervalued With Profitability In SightMay 2, 2025 | seekingalpha.com1 Unprofitable Stock to Target This Week and 2 to Be Wary OfMay 1, 2025 | finance.yahoo.comMyriad Genetics (MYGN) Projected to Post Earnings on TuesdayMyriad Genetics (NASDAQ:MYGN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-myriad-genetics-inc-stock/)May 1, 2025 | marketbeat.comMyriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025May 1, 2025 | seekingalpha.comMyriad Genetics (NASDAQ:MYGN) Reaches New 1-Year Low - What's Next?Myriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - What's Next?April 30, 2025 | marketbeat.comMyriad Genetics (MYGN) Survey Highlights Views on Mental Health Medication | MYGN Stock NewsApril 30, 2025 | gurufocus.com Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address MYGN Media Mentions By Week MYGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYGN News Sentiment▼-0.050.87▲Average Medical News Sentiment MYGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYGN Articles This Week▼118▲MYGN Articles Average Week Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLDX News MNKD News INVA News DVAX News NVAX News OPK News GERN News RGLS News ZBIO News VSTM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYGN) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
